CN103616516A - Applications of SPA-antibody trimer as indicator in detection of blood antigens - Google Patents

Applications of SPA-antibody trimer as indicator in detection of blood antigens Download PDF

Info

Publication number
CN103616516A
CN103616516A CN201310223301.6A CN201310223301A CN103616516A CN 103616516 A CN103616516 A CN 103616516A CN 201310223301 A CN201310223301 A CN 201310223301A CN 103616516 A CN103616516 A CN 103616516A
Authority
CN
China
Prior art keywords
antibody
spa
tripolymer
staphylococcal protein
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310223301.6A
Other languages
Chinese (zh)
Inventor
张厚亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310223301.6A priority Critical patent/CN103616516A/en
Publication of CN103616516A publication Critical patent/CN103616516A/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to applications of an SPA-antibody trimer as an indicator in detection of blood antigens. The trimer is formed of anti erythrocyte antibodies, SPA and some kind of anti leucocyte or other antigen antibodies. The self anti erythrocyte antibodies are combined with erythrocytes, another kind of antibodies are combined with corresponding leucocyte antigens (or other antigens), then leucocytes (or other cells and factors) and erythrocytes are sedimentated through a blood sedimentation process or other methods such as density gradient centrifugation and the like, so the trimer has the effect of removing components of corresponding cells and the like. The trimer also can combine erythrocytes and corresponding antigens by means of SPA and is used for detecting certain antigens.

Description

SPA-antibody tripolymer is as the purposes of the indicator of check blood antigen
The present invention is patent of invention that name is called " SPA-antibody tripolymer, contain this trimerical cell processing kit and its production and use " (application number 201010022753.4, applying date on 01 13rd, the 2010) patent of dividing an application.
Technical field
The present invention relates to field of biomedicine technology, particularly relate to staphylococcal protein A (staphylococalprotein A, hereinafter to be referred as SPA)-antibody tripolymer as the purposes of the indicator of check blood antigen.
Technical background
SPA can the Fc fragment in people and multiple mammalian blood serum IgG molecule be combined.In conjunction with compatibility order be pig, dog, rabbit, people, monkey, mouse, mouse and ox successively.SPA is except being combined with IgG, and IgM and IgA that can also be a small amount of in serum be combined, and the adsorption rate of SPA bacterium to each immunoglobulin like protein: IgG is that 90%～98%, IgM is that 2%～30%, IgA is 1.5%～20%.
The SPA and the IgG that occur coprecipitated reaction must have two binding sites, and they in Fc and Fab section, can be combined with SPA though lack one respectively, do not occur coprecipitated reaction, and the participation of this Fab is not SPA-antibody response.Now study and show, the binding site of IgG and SPA is CH 2and CH 3intersection.
SPA application is very wide, but the principle of all application all be unable to do without SPA, has the binding ability with the Fc section of IgG, and mainly application aspect is as follows:
The coagglutination effect of 1.SPA bacterium
With known standard serum, be adsorbed onto the surface of SPA bacterium, make it to become the carrier of absorption antibody, then go to diagnose corresponding unknown antigen and produce macroscopic agglutinating particle with this, the antigen of diagnosis can be graininess, can be also solubility.This kind of aggegation is equivalent to reverse indirect hemagglutination, but saves the complicated formalities such as the antibody purification in indirect hemagglutination, tanning of red blood cell, and only needs SPA thalline and rough immune serum.So this method is simple, quick, specificity susceptibility is all more satisfied.
2. as wide spectrum second antibody
The second antibody that replaces IgG antibody with SPA, has the following advantages: 1. SPA preparation is easy, stable in properties, and easily purifying, can apply people and multiple mammiferous IgG, not limited by kind.2. the adhesion of SPA is strong, is equivalent to the adhesion of free antibodies and antigen, and the affinity costant of people and rabbit is to 10 3l/ grammol, in conjunction with rear on the activity of IgG without impact.No matter 0 ℃, 37 ℃, 44 ℃ and 56 ℃ almost all can be immediately in conjunction with and without hatching for a long time, therefore can shorten test period; 3. SPA easily puts on 125i, fluorescein, horseradish peroxidase, ferritin etc., therefore can combine with multiple technologies; 4. SPA numberator height homogeneous, it is not immunoglobulin (Ig), not affected by Fc acceptor, so there is higher anti-IgG specificity.
3. for extracting IgG purification, utilize the binding characteristic of SPA and IgG to extract IgG, than routine, adopt ammonium sulfate, Sephadex post, the methods such as DEAE post or immune gradient centrifugation are wanted easy too much, and purity is good.
4. detection and purification IgM IgM are significant in viral early diagnosis, for detection specificity IgM antibody, must first in serum, remove IgG.Adopting SPA bacterium absorption IgG is current quick and desirable way, utilizes this method also for road has been opened up in the purification of IgM.
5. other side is for the detection of detection, Activation In Vitro complement function test, cell surface marker and the TSA of immune complex etc.
Stem cell (stem cell) refers to have unlimited or longer self-renewal capacity, and can differentiate the cell that at least one highly breaks up daughter cell.According to cell derived, stem cell is divided into Embryo stem cell and adult stem cell, and adult stem cell comprises autologous stem cells and allosome stem cell.
Current latest developments both domestic and external impel " stem cell " grafting vessel new life's the mechanism of action, organismic internal environment further to study the effect of the impact of stem cell curative effect and transgenosis marrow derived stem cell, to improve the result for the treatment of of stem cell.
In therapeutic process clinically, the main mononuclearcell that gathers marrow or derived from peripheral blood is transplanted, and think the ancestral cells that CD34+ wherein or CD133+/VEGF-R2+ cell are angiogenesis, but the Proliferation, Differentiation function of this class cell, their ability of the vascular injury site of going back to the nest and the effective quantity etc. that reaches result for the treatment of are all the contents of not yet fully understanding.
Surface antigen (Lineage surface antigen) is when Stem cell differentiation is during for the CFU-GM that is respectively and mature cell, there will be the selectivity sign that is respectively, as Lymphatic System CD19 CD7 granulocyte series CD13, CD11, CD15, CD16, the CD47 of erythron, CD51, CD71, the CD31 of megakaryocytic series CD41 CD42 CD61 CD63 CD107, T NK system CD2 CD25 CD7, it is surface antigen that the antigen that these surfaces of haemocyte in particular type occur is commonly referred to as, Lin antigen positive just can be defined as CFU-GM and mature cell, also have the cell of many Lin antigen negatives to be referred to as primordial stem cell, as CD34 CD133 SCA-1 CD38 etc.We can require the mature cell that removal is relevant to be according to each section office are different.
Stem cell can effectively be treated various cellular damage diseases, and this has been whole world mainstream health care circle admitted facts.But how to obtain stem cell, how separated, purifying is obtained the problem that stem cell survival, very desirable is whole world scientist's joint research.From marrow, Cord blood, the technology of separating and extracting stem cells has much at present, as: immunomagnetic beads method and flow cytometer method etc.The existing common issue of these methods is: first can not effectively retain all types of stem cells, and the second cost is expensive, and technical conditions are had relatively high expectations.On clinical application, there is certain difficulty.
Summary of the invention:
The present invention relates to a kind of staphylococcal protein A (staphylococalprotein A, hereinafter to be referred as SPA)-antibody tripolymer as the purposes of the indicator of check blood antigen.
The invention provides a kind of by the intermediary of red blood cell in blood and other cell/factor combinations: spa-antibody tripolymer, by this tripolymer, can, by red blood cell and needed leucocyte or other cell/factor combinations, by methods such as erythrocyte sedimentation rate or gradient centrifugations, the specific cells/factor in blood can be removed.
Technical scheme of the present invention is:
1.Spa-antibody tripolymer and preparation method thereof:
Material: Recombinant staphylococcus protein A, A antibody: anti-erythrocyte monoclonal or polyclonal antibody, B antibody: can need to select different monoclonals or polyclonal antibody according to clinical and experiment, as: specificity lymphocyte antibody (anti-cd2 antibody, anti-cd3 antibody, anti-cd4 antibody, anti-cd11 antibody, anti-cd15 antibody, anti-cd16 antibody, anti-cd8 antibody, anti-cd19 antibody, anti-cd5 antibody, anti-cd7 antibody, anti-cd13 antibody, anti-cd33 antibody, anti-cd10 antibody, anti-cd21 antibody, anti-cd22 antibody, anti-cd23 antibody, anti-cd32 antibody, anti-cd35 antibody, anti-40cd antibody, anti-cd45 antibody, anti-cd54 antibody, anti-cd56 antibody, anti-cd64 antibody, anti-cd133 antibody, anti-cd117 antibody, anti-cd90 antibody), anti-Marek's virus antibody, anti-HBS antibody, swine fever virus resistant antibody, anti-vibrio parahemolyticus antibody, anti-typhoid antibody etc.
Spa dilutes with aseptic PBS liquid, and A antibody (anti-erythrocyte monoclonal antibody or polyclonal antibody) and B antibody are diluted with antibody diluent, and various dilute concentrations all can (recommending spa be 0.1mg/ml, antibody concentration: 0.1mg/ml dilution).
Raw material mass mixture ratio is: SPA:A is anti-: B resists for 1.5:1:1; As: SPA is 1.5ml, and A resists for 1ml, and B resists for 1ml.(concentration is 0.1mg/ml)
Temperature of reaction 0C～40 ℃ grade all can, recommend 37 ℃ of incubations (water-bath or incubator all can).
Reaction time: 20 minutes-2 hours, recommend 37 ℃ of incubations 30 minutes.
Production concentration: 0.1mg/ml.
Storage requirement: 4 ℃ of storages.
This tripolymer can be for the in-vitro separation kit from human marrow and separated karyocyte Cord blood etc., and it is simple that this technology has method, cheap, can suitability for industrialized production, be easy to the feature of promoting.This technology has effectively been removed blood plasma, red blood cell, blood platelet, plasma proteins, ion, and monocyte, lymphocyte, the apocyte of other required removal moral maturations, and has retained all stem cells, CFU-GM, mescenchymal stem cell etc.This is a kind of application process that can be directly used in clinical separation, extract marrow/umbilical cord/peripheral hematopoietic stem cells in-vitro separation kit of stem cell.
2, cell processing kit: based on above-mentioned tripolymer, bind lymphocytes parting liquid, the chromatoplate of antibody combination, the method that adopts density－gradient centrifuga－tion method, immunochromatographic method and co-immunoprecipitation method to combine, makes cell processing kit.It is characterized in that including in this kit:
SPA(staphylococcal protein A) and the tripolymer of erythrocyte antibody (EA), specificity lymphocyte antibody.The reaction density of SPA and anti-erythrocyte monoclonal antibody and various antilymphocyte antibodys is 0.1～1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, and antilymphocyte antibody is 1ml.In 37 ℃ of water baths, incubation is 30～60 minutes.Adjusting Spa-antibody tripolymer concentration is 1 μ g/ml, and volume is 100ml, PH7.4.4 ℃ of preservations.
Lymphocyte separation medium (commercially available) 50ml.
The chromatoplate of antibody combination: the chromatoplate of polystyrene material, after sterilization, add anti-specificity lymphocyte antibody 0.1～1mg/ml, be paved with surface, 37 ℃ are reacted 30～60 minutes, 4 ℃ of preservations.
Above-mentioned each reagent solution is separately deposited.
The method that the present invention adopts density－gradient centrifuga－tion method, immunochromatographic method and immuno-precipitation to combine, the stem/progenitor cells of collected extraction is without any external label.Can remove different mature lymphocyte system according to different requirements, convenient and simple, can be directly used in clinical, laboratory is separated, extract stem/progenitor cells.
3, the range of application of Spa-antibody:
Be used for clinical diagnosis as indicator, in certain Disease blood, there is special antigen or exotic antigen, the specific antibody of this antigen is connected on Spa-antibody tripolymer, make red blood cell as indicator, cohesion forms " red blood cell-anti erythrocyte antibody-Spa-specific antibody-specific antigen " compound, similar garland spline structure, can be observed visually condensation product or microscopic examination to Kranz structure, as clinical or laboratory diagnosis, uses.
Can pass through Spa-antibody and specific antibody combination, form " red blood cell-anti erythrocyte antibody-Spa-specific antibody " compound, by the method such as centrifugal, make to remove after specific antibody and erythrocyte binding.Can remove patient or specific antibody in blood for experiment.
Can be used in the extraction and purification kit of clinical stem/progenitor cells, in order to the stem/progenitor cells of purifying, increase stem/progenitor cells concentration, improve curative effect.Concrete steps: the antibody that is by specific mature cell is connected on Spa-antibody, form " red blood cell-anti erythrocyte antibody-Spa-lymphocyte antibody-mature lymphocyte ", by the method such as centrifugal, remove mature lymphocyte system etc., make stem/progenitor cells obtain purifying, improve concentration, can be used in the clinical treatment and experimental study of corresponding stem/progenitor cells.
4, the range of application of cell processing kit:
Cell processing kit can be used for extraction and the purifying of the stem/progenitor cells of marrow blood/Cord blood/peripheral blood, concrete application process is: first peripheral blood, marrow or Cord blood are added in the reagent bottle that is placed with chromatoplate, again SPA-antibody tripolymer liquid is poured into wherein, after standing 20 minutes, collect supernatant, by careful the joining above lymphocyte separation medium of supernatant, latter centrifugal 20～30 minutes, collect cellular layer, with the dilution of glucose for injection salt solution, can use.
This cell processing kit also can be used for clinical stem-cell therapy, the treatments such as autogenous bone marrow blood refluxing; Also can be used in experiment, simple to operate, expense is low, and can be by removing corresponding blood constituent, for studying the impacts of composition on the growth of stem/progenitor cells and differentiation such as different mature cell systems and other cell/cell factors.
Embodiment:
Following embodiment will contribute to further to understand the present invention, but can not limit content of the present invention.
Embodiment 1: cell processing kit
SPA(staphylococcal protein A) and the tripolymer of erythrocyte antibody (EA), specificity lymphocyte antibody 1.The reaction density of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and anti-cd3 antibody, cd14 antibody, cd19 antibody, cd56 antibody is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, and anti-cd3 antibody, cd14 antibody, cd19 antibody, cd56 antibody are respectively 0.25ml.In 37 ℃ of water baths, incubation is 30 minutes.Add PBS liquid, adjusting Spa-antibody tripolymer concentration is 1 μ g/ml, and volume is 100ml, PH7.4.4 ℃ of preservations.
2, human lymphocyte parting liquid (commercially available) 100ml, centrifugal density is 1.077g/ml.
3, cell chromatoplate: the chromatoplate of polystyrene material, after sterilization, adding concentration is the anti-cd3 antibody of 0.1mg/ml, cd14 antibody, cd19 antibody, cd56 antibody, be paved with surface, 37 ℃ of reactions were spent the night under room temperature after 30 minutes, put in 500ml reagent bottle.4 ℃ of preservations.
Material therefor is by filtration sterilization, and material is through 120 degrees Celsius, 30 minutes autoclave sterilizations, and reagent is degerming after filtration, after sterile working preparation, leaves in kit respectively.
Cell processing kit application process: get peripheral blood, marrow or Cord blood 200ml, join in the reagent bottle that is placed with chromatoplate, add again 50mlSPA-antibody tripolymer and mix standing 30 minutes of rear 37 degree, this tripolymer respectively with leucocyte, erythrocyte binding, form cell mass, be deposited to test tube bottom.The clone of the unconjugated maturation of part and the antibody on chromatoplate are in conjunction with forming antigen antibody complex.Collect supernatant.Lymphocyte separation medium is added in centrifuge tube, again the supernatant of collecting is carefully added to above lymphocyte separation medium above, centrifugal 20 minutes of 700g, utilize density－gradient centrifuga－tion method to remove remaining red blood cell, blood platelet, blood plasma and unprecipitated leucocyte red blood cell condensate, collect cellular layer, with phosphate buffer (PBS), clean 2-3 time, then use injection physiological saline/glucose saline diluted for use.
Prepared cell can be used for clinical self marrow blood stem-cell therapy, and the stem/progenitor cells dilution of extracting through said process is got involved to the liver internal therapy cirrhosis that is expelled to patient with liver cirrhosis by blood vessel.The lower limb vascular that self the marrow blood stem cell after extracting or cord blood stem cell can be expelled to patient with diabetic feet around and the far-end that is expelled to narrow or occluded artery, treatment diabetes.Also can, by the disconnected injury of spinal cord of extracting self marrow blood stem cell after purifying or cord blood stem cell and being expelled to patients of acute spinal cord injury, treat acute spinal cord transection.Also can be used for other cellular damage disease.
Embodiment 2: cell processing kit
SPA(staphylococcal protein A) and the tripolymer of erythrocyte antibody (EA), specificity lymphocyte antibody 1.The reaction density of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and anti-cd3 antibody, cd14 antibody, cd19 antibody, cd56 antibody is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, and anti-cd3 antibody, cd14 antibody, cd19 antibody, cd56 antibody are 0.25ml.In 37 ℃ of water baths, incubation is 30 minutes.Add PBS liquid, making Spa-antibody tripolymer concentration is 1 μ g/ml, and volume is 100ml, PH7.4.4 ℃ of preservations.
2, the aqueous solution that the Sodium Amidotrizoate of lymphocyte separation medium 100ml:0.3% and 8% ficoll 400# form, density is 1.077g/ml.
3, antibody conjugates: the nano particle of anti-cd3 antibody, cd14 antibody, cd19 antibody, cd56 antibody and polystyrene material is mixed.Antibody concentration is 0.1mg/ml, and volume is 1ml, and granules of polystyrene is 10mg.Incubation ambient temperature overnight after 1 hour in 37 ℃ of water baths.4 ℃ of preservations.
Material therefor is by filtration sterilization, and material is through 120 degrees Celsius, 30 minutes autoclave sterilizations, and reagent is degerming after filtration, after sterile working preparation, leaves in kit respectively.
Cell processing kit application process: get marrow or Cord blood 200ml and add in the reagent bottle containing antibody conjugates, add again 50mlSPA-antibody tripolymer mix latter 37 ℃ standing 30 minutes, this tripolymer respectively with leucocyte, erythrocyte binding, form cell mass, be deposited to test tube bottom.Antibody on the unconjugated eukocyte of part and antibody conjugates suspends in conjunction with forming granule.Collect supernatant.Lymphocyte separation medium is added in centrifuge tube, again the cell suspending liquid of collecting is carefully added to above lymphocyte separation medium above, 2000 revs/min centrifugal 20 minutes, utilize density－gradient centrifuga－tion method to remove remaining red blood cell, blood platelet, blood plasma and antibody conjugates, collect cellular layer, with phosphate buffer (PBS), clean 2-3 time, then with standby after the dilution of injection physiological saline/glucose saline.
Use cell prepared by this kit to can be used for clinical self marrow blood stem-cell therapy, the stem/progenitor cells dilution of extracting through said process is got involved to the liver internal therapy cirrhosis that is expelled to patient with liver cirrhosis by blood vessel.The lower limb vascular that self the marrow blood stem cell after extracting or cord blood stem cell can be expelled to patient with diabetic feet around and the far-end that is expelled to narrow or occluded artery, treatment diabetes.Also can, by the disconnected injury of spinal cord of extracting self marrow blood stem cell after purifying or cord blood stem cell and being expelled to patients of acute spinal cord injury, treat acute spinal cord transection.Also can be used for other cellular damage disease.
Embodiment 3:Spa-antibody
Chicken Marek's disease (MD) is a kind of height lymphoproliferative diseases contagious being caused by MDV.Its principal character is: peripheral nerve, various internal organs, iris and skin etc. lymphocytic infiltration occur and form swollen sick.Marek's disease mainly betides chicken, also has the report of birds such as betiding turkey, pheasant, duck, quail, swan.This disease transmission is strong, and velocity of propagation is fast, and latent period is long.Acute onset chicken is eliminated and mortality ratio reaches 10%～80%.Up to now, in the diagnosis of Marek's disease, except AGPT, still do not have a kind of Neng basic unit to be convenient to the practical technique of application.
SPA(staphylococcal protein A) and the tripolymer of erythrocyte antibody (EA), anti-Marek's virus antibody.The reaction density of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and anti-Marek's virus antibody is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, anti-Marek's virus antibody 1ml.In 37 ℃ of water baths, incubation is 60 minutes.Spa-antibody tripolymer concentration is 0.1mg/ml, PH7.4.4 ℃ of preservations.
During use, this tripolymer is diluted to 1:1000 working concentration, i.e. 0.1 μ g/ml, blood sampling, adds after tripolymer in 37 ℃ of water baths incubation 1 hour, and sampling is originally examined under a microscope, with physiological saline in contrast, person is positive clustering phenomena, has infected MDV.
Embodiment 4:Spa-antibody
Swine fever (SwnieFever, SF) is a kind of height contagious disease of pig.Being a kind of acute, subacute, chronic and typical, the atypical lysis of the pig that caused by CSFV (ClassiealWSnieFeverviurs, CSFV), is one of Infectious Diseases of harm pig industry.
SPA(staphylococcal protein A) and the tripolymer of erythrocyte antibody (EA), swine fever virus resistant antibody.The reaction density of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and swine fever virus resistant antibody is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, swine fever virus resistant antibody 1ml.In 40 ℃ of water baths, incubation is 60 minutes.Spa-antibody tripolymer concentration is 0.1mg/ml, PH7.4.4 ℃ of preservations.
During use, this tripolymer is diluted to 0.1 μ g/ml, and blood sampling adds after tripolymer in 37 ℃ of water baths incubation 1 hour, and sampling is originally examined under a microscope, and with physiological saline in contrast, person is positive clustering phenomena, and this blood sample has infected CSFV.
Embodiment 5:Spa-antibody
Vibrio parahemolyticus (Vibrio parahaemolyticus, VP) is a kind of halophagia pathogen widely distributed in ocean and salt lake.Extensively be distributed in inshore seawater, marine bottom sediment, fish, shellfish, be adapted to grow in the environment of high concentration (6%) salt, containing in the nutrient culture media of salt, can not grow.This bacterium is a kind of common pathogenic entero becteria that is second to comma bacillus, its pollution meeting brings heavy losses to mariculture industry, intestines problem and the food poisoning such as also can cause that the mankind suffer from diarrhoea, occur diarrhoea be water sample or blood sample just, abdominal cramps, feel sick, the symptom such as vomiting and headache.Since two thousand one, the outburst of vibrio parahemolyticus property food poisoning has become Chinese modal disease caused by food-borne bacteria, and a number of vibrio parahemolyticus property food poisoning and number are always in first.
SPA(staphylococcal protein A) and the tripolymer of erythrocyte antibody (EA), anti-vibrio parahemolyticus polyclonal antibody.The reaction density of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and anti-vibrio parahemolyticus polyclonal antibody is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, anti-vibrio parahemolyticus polyclonal antibody 1ml.In 12 ℃ of water baths, incubation is 6 hours.Spa-antibody tripolymer concentration is 0.1mg/ml, PH7.4.4 ℃ of preservations.
During use, this tripolymer dilutes 0.1 μ g/ml, gets blood sample to be measured, add after tripolymer in 37 ℃ of water baths incubation 1 hour, sampling is originally examined under a microscope, with physiological saline in contrast, person is positive clustering phenomena, and this blood sample has infected vibrio parahemolyticus.
Embodiment 6:Spa-antibody
Typhoid fever is the acute infectious disease through transmission being caused by typhoid bacillus.Clinical symptoms is long-range heating, whole body toxicity symptom, relative infrequent pulse, hepatosplenomegaly, roserash and leucocyte minimizing etc.Major complications is enterorrhagia, enterobrosis.
SPA(staphylococcal protein A) and the tripolymer of erythrocyte antibody (EA), anti-typhoid antibody.The reaction density of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and anti-typhoid antibody is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, anti-typhoid antibody 1ml.In 30 ℃ of water baths, incubation is 90 minutes.Spa-antibody tripolymer concentration is 0.1mg/ml, PH7.4.4 ℃ of preservations.
During use, this tripolymer is diluted to 0.1 μ g/ml, and blood sampling adds after tripolymer in 37 ℃ of water baths incubation 1 hour, and sampling is originally examined under a microscope, and with physiological saline in contrast, person is positive clustering phenomena, has infected typhoid fever.
Embodiment 7:Spa-antibody
By spa and anti-erythrocyte monoclonal/polyclonal antibody and different lymphocyte antibody combinations, can be used to detect the ratio of blood lymphocyte subsets, help to judge patient's immunologic function.
SPA(staphylococcal protein A) and erythrocyte antibody (EA), the antibody of lymphocyte subgroup to be measured is (as anti-cd2 antibody, anti-cd3 antibody, anti-cd4 antibody, anti-cd11 antibody, anti-cd15 antibody, anti-cd16 antibody, anti-cd8 antibody, anti-cd19 antibody, anti-cd5 antibody, anti-cd7 antibody, anti-cd13 antibody, anti-cd33 antibody, anti-cd10 antibody, anti-cd21 antibody, anti-cd22 antibody, anti-cd23 antibody, anti-cd32 antibody, anti-cd35 antibody, anti-40cd antibody, anti-cd45 antibody, anti-cd54 antibody, anti-cd56 antibody, anti-cd64 antibody, anti-cd133 antibody, anti-cd117 antibody, anti-cd90 antibody etc.) tripolymer.The reaction density of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and lymphocyte antibody to be measured is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, lymphocyte antibody 1ml to be measured.In 37 ℃ of water baths, incubation is 60 minutes.Spa-antibody tripolymer concentration is 0.1mg/ml, PH7.4.4 ℃ of preservations.
During use, this tripolymer is diluted to 1:1000 working concentration, i.e. 0.1 μ g/ml, blood sampling, adds after tripolymer in 37 ℃ of water baths incubation 45 minutes, naked eyes can be seen agglutination phenomenon, sampling is originally examined under a microscope, and observation aggregated particle is garland spline structure, three red blood cells around positive, counting positive cell number, and standard blood sample result (positive control) is relatively.
Embodiment 8:Spa-antibody
By spa and anti-erythrocyte monoclonal/polyclonal antibody and special cells antibody combination to be measured, whether can be used to detect the existence of cell to be measured in blood.
SPA(staphylococcal protein A) and the tripolymer of the antibody of erythrocyte antibody (EA), special cells to be measured.The reaction density of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and special cells antibody to be measured is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, special cells antibody 1ml to be measured.Standing 12 hours of 4 ℃ of refrigerators.Spa-antibody tripolymer concentration is 0.1mg/ml, PH7.4.4 ℃ of preservations.
During use, this tripolymer is diluted to 1:1000 working concentration, i.e. 0.1 μ g/ml, blood sampling, adds after tripolymer in 37 ℃ of water baths incubation 1 hour, naked eyes can be seen agglutination phenomenon, sampling is originally examined under a microscope, and observation aggregated particle is garland spline structure, three red blood cells around positive, counting positive cell number, and standard blood sample result (positive control) is relatively.
Spa-antibody embodiment 9:
By the antibody combination of spa and anti-erythrocyte monoclonal/polyclonal antibody and tumor associated antigen to be measured, whether can be used to detect the existence of tumor associated antigen to be measured in blood.
SPA(staphylococcal protein A) and the tripolymer of the antibody of erythrocyte antibody (EA), tumor associated antigen to be measured.The reaction density of the antibody of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and tumor associated antigen to be measured is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, the antibody 1ml of tumor associated antigen to be measured.Standing 3 hours of 20 ℃ of refrigerators.Spa-antibody tripolymer concentration is 0.1mg/ml, PH7.4.4 ℃ of preservations.
During use, this tripolymer is diluted to 1:1000 working concentration, i.e. 0.1 μ g/ml, blood sampling, adds after tripolymer in 37 ℃ of water baths incubation 1 hour, naked eyes can be seen agglutination phenomenon, sampling is originally examined under a microscope, and observation aggregated particle is garland spline structure, three red blood cells around positive, counting positive cell number, and standard blood sample result (positive control) is relatively.
Spa-antibody embodiment 10:
By spa and anti-erythrocyte monoclonal/polyclonal antibody and cytokine antibodies combination to be measured, whether can be used to detect the existence of the special cells factor in blood.
SPA(staphylococcal protein A) and the tripolymer of the antibody of erythrocyte antibody (EA), cell factor to be measured.The reaction density of this tripolymer preparation process: SPA and anti-erythrocyte monoclonal antibody and cytokine antibodies to be measured is 0.1mg/ml.SPA is 1.5ml, and anti-erythrocyte monoclonal antibody is 1ml, treats cytokine antibodies 1ml.Standing 2 hours of 25 ℃ of refrigerators.Spa-antibody tripolymer concentration is 0.1mg/ml, PH7.4.4 ℃ of preservations.
During use, this tripolymer is diluted to 1:1000 working concentration, i.e. 0.1 μ g/ml, blood sampling, adds after tripolymer in 37 ℃ of water baths incubation 1 hour, naked eyes can be seen agglutination phenomenon, sampling is originally examined under a microscope, and observation aggregated particle is garland spline structure, three red blood cells around positive, counting positive cell number, and standard blood sample result (positive control) is relatively.

Claims (5)

1. a purposes for staphylococcal protein A-antibody tripolymer, is characterized in that: for the indicator as check blood antigen; Described tripolymer is the combination of staphylococcal protein A synantibody A, antibody B, and described antibody A is anti-erythrocyte monoclonal antibody or polyclonal antibody, and described antibody B is monoclonal antibody to be measured or polyclonal antibody.
2. purposes as claimed in claim 1, it is characterized in that: while checking the indicator of blood antigen for conduct, to realize by following steps: the specific antibody of this determined antigen is connected on staphylococcal protein A-antibody tripolymer, make red blood cell as indicator, cohesion forms " red blood cell-anti erythrocyte antibody-staphylococcal protein A-specific antibody-specific antigen " compound, is observed visually condensation product or microscopic examination to Kranz structure.
3. purposes as claimed in claim 1, it is characterized in that: described staphylococcal protein A-antibody tripolymer is obtained by following preparation method: staphylococcal protein A is diluted with aseptic phosphate buffer, A antibody and B antibody are diluted with antibody diluent, at 0 ℃ or 4～40 ℃ of temperature, incubation 20 minutes-12 hours, obtain described staphylococcal protein A-antibody tripolymer, wherein, the mass ratio of described staphylococcal protein A, A antibody and B antibody is 1.5:1:1; Described tripolymer is the combination of staphylococcal protein A synantibody A, antibody B, and described antibody A is anti-erythrocyte monoclonal antibody or polyclonal antibody, and described antibody B is monoclonal antibody to be measured or polyclonal antibody.
4. the purposes as described in claim 1 or 3, is characterized in that: described antibody B is arbitrary antibody in specificity lymphocyte antibody, anti-Marek's virus antibody, anti-HBS antibody, swine fever virus resistant antibody, anti-vibrio parahemolyticus antibody, anti-typhoid antibody.
5. purposes as claimed in claim 4, it is characterized in that: described specificity lymphocyte antibody is anti-cd2 antibody, anti-cd3 antibody, anti-cd4 antibody, anti-cd11 antibody, anti-cd15 antibody, anti-cd16 antibody, anti-cd8 antibody, anti-cd19 antibody, anti-cd5 antibody, anti-cd7 antibody, anti-cd13 antibody, anti-cd33 antibody, anti-cd10 antibody, anti-cd21 antibody, anti-cd22 antibody, anti-cd23 antibody, anti-cd32 antibody, anti-cd35 antibody, anti-40cd antibody, anti-cd45 antibody, anti-cd54 antibody, anti-cd56 antibody, anti-cd64 antibody, anti-cd133 antibody, anti-cd117 antibody, the combination of one or more in anti-cd90 antibody.
CN201310223301.6A 2010-01-13 2010-01-13 Applications of SPA-antibody trimer as indicator in detection of blood antigens Pending CN103616516A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310223301.6A CN103616516A (en) 2010-01-13 2010-01-13 Applications of SPA-antibody trimer as indicator in detection of blood antigens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310223301.6A CN103616516A (en) 2010-01-13 2010-01-13 Applications of SPA-antibody trimer as indicator in detection of blood antigens

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201010022753.4A Division CN101799473B (en) 2010-01-13 2010-01-13 SPA-antibody tripolymer, cell treating kit containing tripolymer, preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN103616516A true CN103616516A (en) 2014-03-05

Family

ID=50167222

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310223301.6A Pending CN103616516A (en) 2010-01-13 2010-01-13 Applications of SPA-antibody trimer as indicator in detection of blood antigens

Country Status (1)

Country Link
CN (1) CN103616516A (en)

Similar Documents

Publication Publication Date Title
CN101799473B (en) SPA-antibody tripolymer, cell treating kit containing tripolymer, preparation method and application thereof
Bücheler et al. Alloantibodies against A and B blood types in cats
Macher et al. Complement depletion in cryptococcal sepsis
Israels et al. Platelet Fc receptor as a mechanism for Ag-Ab complex-induced platelet injury
ES2737731T5 (en) Affinity chromatography media for removal of anti-A and/or anti-B antibodies
Wilson Studies on the opsonic activity of human secretory IgA using an in vitro phagocytosis system
CN101144070A (en) Marrow umbilical cord blood stem cell in vitro separating kit and application method thereof
Petz Bystander immune cytolysis
Johnson et al. Immunopathology of the lung: a review.
CN106267422A (en) Rh blood group incompatibility Hemolysis therapeutic instrument
Skogen et al. Minimal expression of blood group A antigen on thrombocytes from A2 individuals
Rynnel-Dagöö Polyclonal activation to immunoglobulin secretion in human adenoid lymphocytes induced by bacteria from nasopharynx in vitro
Adelson et al. Studies on platelets: VI. Demonstration and characterization of a heterologous (Forssman) platelet agglutinin
CN103361313A (en) Kit and use of SPA (staphylococcal protein A)-antibody trimer
Van der Lelie et al. Platelet autoantibodies in septicaemia
Kuckleburg et al. Bovine platelets activated by Haemophilus somnus and its LOS induce apoptosis in bovine endothelial cells
Chou et al. CELLS AS ANTIGEN CARRIERS AND AS IMMUNOGLOBULIN PRODUCERS: Synthesis of Antibody and Allogeneic Immunoglobulin after Transfer of Antigen-Treated Cells to Newborn Rabbits
CN103616516A (en) Applications of SPA-antibody trimer as indicator in detection of blood antigens
CN103604927A (en) SPA-antibody trimer for eliminating specific antibodies in blood
CN102174470A (en) Cell processing kit
Witebsky et al. A simple method for the concentration of Rh agglutinins
Soltys et al. Altered lymphocyte reactivity to E. coli in chronic pyelonephritis
Hook et al. Appearance of natural antibodies in young rabbits
Williams et al. Lymphocytes binding C-reactive protein and streptococcal membranes in acute rheumatic fever
Amemiya et al. The nature of antiplatelet activity in antilymphoblast ALG: with special reference to crossreacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140305